| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Antibe Therapeutics Inc. (TO: ATE)
ATE Technical Analysis
5
| As on 24th May 2024 ATE STOCK Price closed @ 0.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.54 & Strong Sell for SHORT-TERM with Stoploss of 0.56 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATESTOCK Price
| Open | 0.30 | Change | Price | % |
| High | 0.30 | 1 Day | 0.00 | 0.00 |
| Low | 0.30 | 1 Week | 0.00 | 0.00 |
| Close | 0.30 | 1 Month | 0.00 | 0.00 |
| Volume | N/A | 1 Year | -0.18 | -37.50 |
| 52 Week High 1.18 | 52 Week Low 0.16 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| TRP | 76.94 | % |
| CNQ | 46.47 | % |
| UEX | 0.50 | 16.28% |
| CVE | 23.35 | % |
| SU | 60.97 | % |
| T | 17.87 | % |
| SJR-B | 40.48 | 0.02% |
| MEG | 30.89 | 0.72% |
| WEED | 1.59 | % |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| ATE Daily Charts |
ATE Intraday Charts |
Whats New @ Bazaartrend |
ATE Free Analysis |
|
|
ATE Important Levels Intraday
| RESISTANCE | 0.30 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.30 |
ATE Forecast December 2025
| 4th UP Forecast | 0.59 |
| 3rd UP Forecast | 0.5 |
| 2nd UP Forecast | 0.44 |
| 1st UP Forecast | 0.38 |
| 1st DOWN Forecast | 0.22 |
| 2nd DOWN Forecast | 0.16 |
| 3rd DOWN Forecast | 0.1 |
| 4th DOWN Forecast | 0.01 |
ATE Weekly Forecast
| 4th UP Forecast | 0.43 |
| 3rd UP Forecast | 0.39 |
| 2nd UP Forecast | 0.36 |
| 1st UP Forecast | 0.34 |
| 1st DOWN Forecast | 0.26 |
| 2nd DOWN Forecast | 0.24 |
| 3rd DOWN Forecast | 0.21 |
| 4th DOWN Forecast | 0.17 |
ATE Forecast2025
| 4th UP Forecast | 2.38 |
| 3rd UP Forecast | 1.71 |
| 2nd UP Forecast | 1.3 |
| 1st UP Forecast | 0.89 |
| 1st DOWN Forecast | -0.29 |
| 2nd DOWN Forecast | -0.7 |
| 3rd DOWN Forecast | -1.11 |
| 4th DOWN Forecast | -1.78 |
Antibe Therapeutics Inc. ( TO Canada Symbol : ATE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATE Business Profile
Antibe Therapeutics Inc., a biotechnology company, originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. The company's lead compound is Otenaproxesul, a hydrogen sulfide-releasing derivative of naproxen for treating rheumatoid arthritis, ankylosing spondylitis, and general pain reduction that has completed Phase 2B gastrointestinal safety study. Its products also comprise ATB-352, which is in preclinical stage for the treatment of gout, dental pain, post-surgical pain, etc.; and ATB-340 that is in preclinical development stage for the treatment of stroke and cancer. In addition, it offers bone graft substitutes, barrier membranes, and other products for the dental and orthopedic markets under the C-Graft Putty, C-Blast Putty, Eclipse, NeoGuarde, Neomem, Neomem FlexPlus, PentOS OI, and Raptos trademarks. The company was incorporated in 2009 and is headquartered in Toronto, Canada. Address: 15 Prince Arthur Avenue, Toronto, ON, Canada, M5R 1B2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service